Last reviewed · How we verify
NCT07509931
Empowerment Training for Personal Agency Development of Primary Health Care Workers
NA trial testing Empowerment Agency Training (EAT) in Data Accuracy in 200 participants. Not yet recruiting.
30 September 2026
Quick facts
| Lead sponsor | Oxford University Clinical Research Unit Indonesia |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | sequential |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 200 |
| Start date | 10 April 2026 |
| Primary completion | 30 September 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 2 locations across Indonesia |
Drugs / interventions tested
- Empowerment Agency Training (EAT)
Conditions studied
- Data Accuracy — all drugs for Data Accuracy →
- Agency — all drugs for Agency →
- Burnout — all drugs for Burnout →
- Service Evaluation — all drugs for Service Evaluation →
Sponsor
Oxford University Clinical Research Unit Indonesia
Who can join
Eligibility, any sex, with Data Accuracy or Agency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates an Empowerment Agency Training (EAT) intervention within the SPHERES programme that aims to strengthen personal agency among workers in primary healthcare centers (Puskesmas) in Indonesia. The intervention focuses on building self-efficacy, behavioural control, leadership, and intentional decision-making through structured training, follow-up action planning, observational support, and sustainability-oriented incentives. Strengthening personal agency is expected to improve the use of data for decision-making and the delivery of priority primary health services at the Puskesmas level.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07509931
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Oxford University Clinical Research Unit Indonesia trials
Trials by the same sponsor.
- NCT07126041 — Scalable Public Health Empowerment, Research, and Education Sites (SPHERES) · NA · not yet recruiting
- NCT05243654 — Efficacy and Tolerability of Adjunct Metformin for Multibacillary Leprosy · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07509931 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Oxford University Clinical Research Unit Indonesia
- Last refreshed: 3 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07509931.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing